Isopto-Maxidex

Dexamethasone, the active ingredient in Isopto-Maxidex, is a glucocorticoid presented as a 0.1% w/v ophthalmic suspension for ocular use. It reduces inflammation in postoperative eyes, uveitis, allergic conjunctivitis and other inflammatory eye conditions, providing targeted therapy for patients requiring corticosteroid eye drops and is indicated for short‑term management of ocular inflammation to preserve visual function.

GNH USA supplies Isopto-Maxidex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on consistent potency and safety.

Isopto-Maxidex (dexamethasone) is a glucocorticoid ophthalmic suspension used to manage inflammatory eye conditions. - Post‑operative ocular inflammation: reduces swelling and pain after eye surgery. - Uveitis: controls intra‑ocular inflammation and prevents tissue damage. - Allergic conjunctivitis: alleviates redness, itching and swelling caused by allergens.

Isopto-Maxidex may cause ocular and systemic adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Eye irritation: transient burning or stinging after instillation. - Increased intraocular pressure: mild rise detectable on routine exams. - Blurred vision: temporary reduction in visual clarity. - Conjunctival hyperemia: mild redness of the eye.

Serious or Rare Side Effects: - Severe ocular hypertension: significant pressure increase requiring treatment. - Secondary glaucoma: optic nerve damage due to pressure elevation. - Infectious keratitis: corneal infection that may threaten vision. - Hypersensitivity reaction: swelling, rash, or anaphylaxis.

When prescribing Isopto-Maxidex, clinicians should observe several precautions to minimize risks. - Assess intraocular pressure: baseline measurement before initiating therapy. - Limit duration: use the lowest effective dose for the shortest period. - Monitor for infection: avoid use in active ocular infections unless necessary. - Caution in glaucoma patients: may exacerbate pressure elevation. - Avoid contact lens wear: remove lenses before and after instillation. - Store at room temperature: keep below 25°C, protect from moisture and light in original container.

Isopto-Maxidex can interact with other ocular or systemic agents, influencing efficacy or safety.

Major Interactions (Avoid): - Systemic corticosteroids: additive systemic glucocorticoid effects. - Anticholinergic eye drops: may reduce drug absorption. - CYP3A4 inhibitors (e.g., ketoconazole eye drops): increase local dexamethasone levels.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory eye drops: potential additive irritation. - Antiviral eye medications: monitor for reduced antiviral efficacy. - Beta‑blocker eye drops: observe for intraocular pressure changes.